These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15886823)

  • 1. Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux.
    Kuo KH; Kovacs MJ
    Thromb Haemost; 2005 May; 93(5):999-1000. PubMed ID: 15886823
    [No Abstract]   [Full Text] [Related]  

  • 2. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin.
    Warkentin TE
    Thromb Haemost; 2008 Jan; 99(1):2-3. PubMed ID: 18217128
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman.
    Leporini C; Rende A; Sorrentino A; Rizzica E; Russo E; Gallelli L; De Sarro G
    J Clin Pharmacol; 2013 Sep; 53(9):999-1002. PubMed ID: 23832870
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
    Snodgrass MN; Shields J; Rai H
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: nephrologists between two fires.
    Solak Y; Demircioglu S; Polat I; Biyik Z; Gaipov A; Acar K; Turk S
    Hemodial Int; 2013 Apr; 17(2):320-3. PubMed ID: 22631215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia successfully treated with fondaparinux.
    Seldrum S; Lambert M; Hainaut P
    Acta Clin Belg; 2009; 64(2):144-6. PubMed ID: 19432027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study.
    Kang M; Alahmadi M; Sawh S; Kovacs MJ; Lazo-Langner A
    Blood; 2015 Feb; 125(6):924-9. PubMed ID: 25515959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How we manage patients with heparin induced thrombocytopenia.
    Scully M; Gates C; Neave L
    Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent off-label use of fondaparinux in patients with suspected acute heparin-induced thrombocytopenia (HIT)--findings from the GerHIT multi-centre registry study.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Kropff S; Müller MM; Lindhoff-Last E
    Thromb Res; 2014 Jul; 134(1):29-35. PubMed ID: 24703295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux as a treatment option for heparin-induced thrombocytopenia.
    Papadopoulos S; Flynn JD; Lewis DA
    Pharmacotherapy; 2007 Jun; 27(6):921-6. PubMed ID: 17542773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II.
    Haase M; Bellomo R; Rocktaeschel J; Ziemer S; Kiesewetter H; Morgera S; Neumayer HH
    Nephrol Dial Transplant; 2005 Feb; 20(2):444-6. PubMed ID: 15673695
    [No Abstract]   [Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia in a patient treated with fondaparinux.
    Ratuapli SK; Bobba B; Zafar H
    Clin Adv Hematol Oncol; 2010 Jan; 8(1):61-5. PubMed ID: 20351685
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.
    Al-Rossaies A; Alkharfy KM; Al-Ayoubi F; Al-Momen A
    Int J Clin Pharm; 2011 Dec; 33(6):997-1001. PubMed ID: 22002684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
    Blackmer AB; Oertel MD; Valgus JM
    Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
    Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
    J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of fondaparinux early after mechanical aortic valve replacement in a patient with a history of heparin-induced thrombocytopenia.
    Willenborg KL
    Pharmacotherapy; 2014 Jun; 34(6):e55-9. PubMed ID: 24644124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed-onset heparin-induced thrombocytopenia type-2 during fondiparinux (Arixtra) therapy.
    Modi C; Satani D; Cervellione KL; Cervantes J; Gintautas J
    Proc West Pharmacol Soc; 2009; 52():5-7. PubMed ID: 22128408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in heparin-induced thrombocytopenia: diagnosis and management.
    Spinler SA
    J Thromb Thrombolysis; 2006 Feb; 21(1):17-21. PubMed ID: 16475037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.